NCT05136807: Quality of Life in Patients With Asymptomatic Monoclonal Gammopathies

NCT05136807: Quality of Life in Patients With Asymptomatic Monoclonal Gammopathies

NCT05136807: Quality of Life in Patients With Asymptomatic Monoclonal Gammopathies

This study examines the quality of life in patients with monoclonal gammopathy of unknown significance and smoldering multiple myeloma. Collecting quality of life information from patients may help doctors learn more about the most common symptoms and concerns patients with monoclonal gammopathy of unknown significance and smoldering multiple myeloma may have.

Sponsor

M.D. Anderson Cancer Center

Collaborator

National Cancer Institute (NCI)

---

ClinicalTrials.gov Identifier: NCT05136807

Official Title: Quality of Life in Patients With Asymptomatic Monoclonal Gammopathies

First Posted : November 29, 2021

Click here to see details on ClinicalTrials.gov

---

Other: Quality-of-Life Assessment Other: Questionnaire Administration

---

Location

United States, Texas